We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Evotec Awarded Contract to Manage NCI CBC Screening Libraries Center

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Evotec AG has announced that it has entered into a multi-year compound management agreement with the U.S. National Cancer Institute ("NCI"), Department of Health and Human Services. Under the terms of the agreement, Evotec will provide compound management services to the NCI Chemical Biology Consortium ("CBC") for a period of five years with a total estimated value of up to EUR 4.5 m ($ 4.9 m).

The NCI Chemical Biology Consortium contract will continue to provide to acquire, store, maintain and distribute the current library collection. This repository will form part of the CBC's drug discovery and development platform for new oncology therapeutics being researched by a consortium of primarily academic and non-profit institutions.

Dr Mario Polywka, Chief Operating Officer of Evotec, commented: "We are pleased the NCI has elected to award Evotec this important contract to support the Chemical Biology Consortium, an important initiative in the discovery of new cancer treatments."